Cargando…

Evaluation of a Patient CAM-with-Chemotherapy Educational Brochure

Biologically active CAM may detrimentally interfere with chemotherapy treatment, so cancer patients require targeted, evidence-based information on chemotherapy-CAM integration consequences. The object of this study was to investigate the potential for medical doctor recommendation and patient accep...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Peter J., Clavarino, Alexandra M., Long, Jeremy E., Steadman, Kathryn J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352944/
https://www.ncbi.nlm.nih.gov/pubmed/25802538
http://dx.doi.org/10.1155/2015/408430
_version_ 1782360533047967744
author Smith, Peter J.
Clavarino, Alexandra M.
Long, Jeremy E.
Steadman, Kathryn J.
author_facet Smith, Peter J.
Clavarino, Alexandra M.
Long, Jeremy E.
Steadman, Kathryn J.
author_sort Smith, Peter J.
collection PubMed
description Biologically active CAM may detrimentally interfere with chemotherapy treatment, so cancer patients require targeted, evidence-based information on chemotherapy-CAM integration consequences. The object of this study was to investigate the potential for medical doctor recommendation and patient acceptance of a purpose-designed patient educational brochure on the safe use of CAM with chemotherapy. Cancer care doctors (n = 17) were provided a draft version of a patient educational brochure developed by the authors and completed a structured feedback form. Cancer patients receiving treatment (n = 12) were provided with the brochure and completed the local health service consumer testing feedback form. All 17 doctors perceived a need for the brochure and all would recommend the brochure to their patients. Approximately 59% of the doctors indicated they would recommend the brochure to all patients receiving chemotherapy and 41% preferred that only patients using CAM or who enquired about CAM be given the brochure. Cancer patients receiving chemotherapy reported that the brochure information answered their questions and was easy to understand. This evidence-based CAM-chemotherapy patient brochure may be a useful adjunct for use by cancer care health professionals to educate patients on the potential dangers of biologically active CAM use with chemotherapy and to provide patients with safe CAM alternatives.
format Online
Article
Text
id pubmed-4352944
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-43529442015-03-23 Evaluation of a Patient CAM-with-Chemotherapy Educational Brochure Smith, Peter J. Clavarino, Alexandra M. Long, Jeremy E. Steadman, Kathryn J. Evid Based Complement Alternat Med Research Article Biologically active CAM may detrimentally interfere with chemotherapy treatment, so cancer patients require targeted, evidence-based information on chemotherapy-CAM integration consequences. The object of this study was to investigate the potential for medical doctor recommendation and patient acceptance of a purpose-designed patient educational brochure on the safe use of CAM with chemotherapy. Cancer care doctors (n = 17) were provided a draft version of a patient educational brochure developed by the authors and completed a structured feedback form. Cancer patients receiving treatment (n = 12) were provided with the brochure and completed the local health service consumer testing feedback form. All 17 doctors perceived a need for the brochure and all would recommend the brochure to their patients. Approximately 59% of the doctors indicated they would recommend the brochure to all patients receiving chemotherapy and 41% preferred that only patients using CAM or who enquired about CAM be given the brochure. Cancer patients receiving chemotherapy reported that the brochure information answered their questions and was easy to understand. This evidence-based CAM-chemotherapy patient brochure may be a useful adjunct for use by cancer care health professionals to educate patients on the potential dangers of biologically active CAM use with chemotherapy and to provide patients with safe CAM alternatives. Hindawi Publishing Corporation 2015 2015-02-23 /pmc/articles/PMC4352944/ /pubmed/25802538 http://dx.doi.org/10.1155/2015/408430 Text en Copyright © 2015 Peter J. Smith et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Smith, Peter J.
Clavarino, Alexandra M.
Long, Jeremy E.
Steadman, Kathryn J.
Evaluation of a Patient CAM-with-Chemotherapy Educational Brochure
title Evaluation of a Patient CAM-with-Chemotherapy Educational Brochure
title_full Evaluation of a Patient CAM-with-Chemotherapy Educational Brochure
title_fullStr Evaluation of a Patient CAM-with-Chemotherapy Educational Brochure
title_full_unstemmed Evaluation of a Patient CAM-with-Chemotherapy Educational Brochure
title_short Evaluation of a Patient CAM-with-Chemotherapy Educational Brochure
title_sort evaluation of a patient cam-with-chemotherapy educational brochure
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352944/
https://www.ncbi.nlm.nih.gov/pubmed/25802538
http://dx.doi.org/10.1155/2015/408430
work_keys_str_mv AT smithpeterj evaluationofapatientcamwithchemotherapyeducationalbrochure
AT clavarinoalexandram evaluationofapatientcamwithchemotherapyeducationalbrochure
AT longjeremye evaluationofapatientcamwithchemotherapyeducationalbrochure
AT steadmankathrynj evaluationofapatientcamwithchemotherapyeducationalbrochure